What Does Compliance Aware Production Mean for a Pharmaceutical Event?

Compliance aware production means building regulatory requirements into an event from the first planning conversation, not applying them after the plan is already built.

• Compliance is planned into the brief from day one, not reviewed in once the plan is already built.

• The ABPI code and equivalent codes apply to filmed, hybrid and streamed content, not just the physical room.

• Content approval runs through medical, legal and regulatory review as well as client sign off.

Why pharmaceutical events are not like other events

A product launch or a technology conference is judged on how it looks and how it lands. As is a pharmaceutical event, but it is also judged against a code of practice, a set of disclosure rules and, often, more than one regulator at once. The ABPI code in the UK, and equivalent codes in every other market a global pharmaceutical brand operates in, shape what can be said, filmed, recorded and shared, and by whom.

This is not a legal technicality that sits behind the scenes. It changes decisions that get made on the day: who is allowed on camera, what gets included in a highlights reel, how a healthcare professional's contribution is credited, and how quickly a recording can be released once compliance has reviewed it.

What compliance aware production covers in practice

• Content approval workflows built around medical, legal and regulatory review as well as client sign off.

• Clear consent and recording protocols for every healthcare professional or patient appearing on camera or in the room.

• Disclosure signage and onsite messaging that meets the requirements of the market the event is being held in, and every market the content will be distributed to afterwards.

• An understanding that a global congress streamed into several countries at once may need to satisfy several different codes simultaneously, not just the one governing the physical venue.

• Secure handling of medical content, from raw footage through to the final edit, with an audit trail that a compliance team can actually follow.

Why this matters more at global scale

A single market event is hard enough to get right. A hybrid pharmaceutical congress broadcasting to audiences across multiple countries multiplies the compliance surface area, because each market can have its own interpretation of what is permitted. Production planning has to account for the strictest applicable rule, not the most convenient one.

How World Wide Group approaches this

We are not a compliance consultancy, and we do not pretend to be one. What 90+ years of production heritage across 80+ countries gives us is the pattern recognition to know where the compliance conversation needs to happen early, and the discipline to build our production schedule around it rather than around it as an afterthought. We work alongside the client's medical, legal and regulatory teams from the brief stage, so the production plan and the compliance sign off are moving together, not fighting each other in the final week.

If you are planning a pharmaceutical congress, product event or hybrid medical meeting and want to talk through what compliance aware production would look like for your brief, our pharmaceutical events page has more detail, or you can get in touch directly.

FREQUENTLY ASKED QUESTIONS

What is compliance aware production?

Compliance aware production is event production planned around the regulatory and disclosure requirements of the pharmaceutical sector from the outset, rather than reviewed for compliance after the plan is already built. It covers consent, disclosure, content approval and recording protocols for healthcare professional and patient involvement.

Does the ABPI code apply to hybrid and streamed pharmaceutical events?

Yes. The ABPI code and equivalent codes in other markets apply to hybrid and streamed content in the same way they apply to a physical room, and a global stream can trigger several codes at once depending on where it is viewed.

Who reviews content for a compliance aware pharmaceutical production?

Content is typically reviewed by the client's medical, legal and regulatory teams alongside the production team, with sign off built into the schedule from the brief stage rather than added at the end.